产品名称

英文名称：Ostarine

同义词

Ostarine、ENOBOSARM、841205-47-8、GTx-024、MK-2866、1202044-20-9、Ostarine(MK-2866)、Enobosarm [USAN]、MK-2866 (GTx-024)、Ostarine (MK2866)、Ostarine(MK-2286)、(2s)-3-(4-Cyanophenoxy)-N-[4-Cyano-3-(Trifluoromethyl)phenyl]-2-Hydroxy-2-Methylpropanamide、(S)-N-(4-Cyano

产品性质

CAS编号：841205-47-8

分子式：C19H14F3N3O3

分子量：389.33

Beilstein号：10201846

MDL号：MFCD16877675

PubChem编号：11326715

英文别名：Ostarine|ENOBOSARM|841205-47-8|GTx-024|MK-2866|1202044-20-9|Ostarine(MK-2866)|Enobosarm [USAN]|MK-2866 (GTx-024)|Ostarine (MK2866)|Ostarine(MK-2286)|(2s)-3-(4-Cyanophenoxy)-N-[4-Cyano-3-(Trifluoromethyl)phenyl]-2-Hydroxy-2-Methylpropanamide|(S)-N-(4-Cyano

规格或纯度：≥99%

英文名称：Ostarine

生化机理：Ostarine (MK-2866) is an androgen receptor modulator (SARM) with an ED50 of 0.44 mg/day. Ostarine (MK-2866) has anabolic activity. Lack of PSA increases in men and hair growth in women further corroborated selective anabolic effects of Ostarine (MK-2866). Ostarine (MK-2866) also resulted in a dose-dependent decrease in LDL and HDL cholesterol levels, with the average LDL/HDL ratio for all doses remaining in the low cardiovascular risk catergory.

储存温度：-20°C储存,充氩

运输条件：超低温冰袋运输

备注：卖完停产，不再备货

产品介绍：MK-2866 (GTx-024)是一种selective androgen receptor modulator (SARM)（选择性雄激素受体调节剂） ， Ki为3.8 nM，作用于合成代谢器官具有组织选择性。Phase 3。A modulator to human androgen receptor. Ostarine at the concentration of 10 nM modulates the transcriptional activity of AR in CV-1 cells cotransfected with a human AR expression vector, a luciferase reporter vector, and a control β-galactosidase vector, with 94%-100% relative activity of the transcriptional activation observed for 1 nM DHT.MK-2866 (GTx-024) is a selective androgen receptor modulator (SARM) with Ki of 3.8 nM, and is tissue-selective for anabolic organs. Phase 3.A modulator to human androgen receptor. Ostarine at the concentration of 10 nM modulates the transcriptional activity of AR in CV-1 cells cotransfected with a human AR expression vector, a luciferase reporter vector, and a control β-galactosidase vector, with 94%-100% relative activity of the transcriptional activation observed for 1 nM DHT.

ALogP：2.7

IUPAC Name：(2S)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide

INCHI：InChI=1S/C19H14F3N3O3/c1-18(27,11-28-15-6-2-12(9-23)3-7-15)17(26)25-14-5-4-13(10-24)16(8-14)19(20,21)22/h2-8,27H,11H2,1H3,(H,25,26)/t18-/m0/s1

InChi Key：JNGVJMBLXIUVRD-SFHVURJKSA-N

Canonical SMILES：CC(COC1=CC=C(C=C1)C#N)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O

Isomeric SMILES：C[C@](COC1=CC=C(C=C1)C#N)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O

PubChem CID：11326715

溶解性：DMSO

产品包装